Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers, with a 5-year survival rate of less than 5%. In fact, complete surgical resection remains the only curative treatment. However, fewer than 20% of patients are candidates for surgery at the time of presentation....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Martín-Blázquez, Ariadna, Jiménez-Luna, Cristina, Díaz, Caridad, Martínez-Galán, Joaquina, Prados, Jose, Vicente, Francisca, Melguizo, Consolación, Genilloud, Olga, Pérez del Palacio, José, Caba, Octavio
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225994/
https://ncbi.nlm.nih.gov/pubmed/32325731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12041002
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki